Skip to main content
. 1999 May;154(5):1439–1447. doi: 10.1016/s0002-9440(10)65398-9

Figure 5.

Figure 5.

Caspase-3 activity in anti-CD95-treated CHD cell lines. Positive control for caspase-3 activity is demonstrated in Jurkat T cells by fivefold induction of caspase-3 activity after 24 hours of agonistic CD95 mAb treatment. HS445 and L428 cell lines had approximately ten-fold increases in caspase-3 activity after 48 hours’ treatment with anti-CD95 mAb compared to untreated controls. In contrast, no significant increase in caspase-3 activity was detected in anti-CD95-treated KMH2 cells when compared to untreated cells. These data are representative of three separate experiments.